Further Advances in Electrocardiography, Cardiac Arrhythmias, and Arrhythmogenic Disorders

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 20 November 2024 | Viewed by 1167

Special Issue Editor


E-Mail Website
Guest Editor
Department of Electrocardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, The John Paul II Hospital, Kraków, Poland
Interests: cardiac arrhythmias; arrhythmogenic disorders; atrial fibrillation; cardiac pacing; implantable cardioverter-defibrillators; cardiac resynchronization therapy; catheter ablation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Novel electrocardiographic criteria, along with new algorithms for the diagnostics and treatment of arrhythmias, have been proposed, enabling more personalized patient management, including the more rational use of imaging, implantable cardioverter-defibrillators, cardiac resynchronization therapy, and catheter ablation. The progress also concerns the diagnostics, treatment, and classification of arrhythmogenic disorders. Moreover, advancements in imaging and cardiovascular genetics make better diagnostics and risk stratification possible; however, personalized paths in arrhythmia management are increasingly needed.

This Special Issue of the Journal of Clinical Medicine, “Further Advances in Electrocardiography, Cardiac Arrhythmias and Arrhythmogenic Disorders”, will focus on recent improvements, developments, and findings in the fields of diagnostics and the treatment of cardiac arrhythmias as well as arrhythmogenic disorders, including channelopathies and cardiomyopathies. Furthermore, papers summarizing the current state of knowledge, papers on arrhythmias related to specific diseases (e.g., sleep apnea) or disciplines, and those highlighting potential gaps in our understanding of cardiac arrhythmias are also welcome.  

It is my pleasure to invite you to contribute to this Special Issue. This is a new volume; we published 22 papers in the first volume. For more details, please visit the following link: https://www.mdpi.com/journal/jcm/special_issues/cardiac_arrhythmias_research.

Dr. Paweł T. Matusik
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • electrocardiography
  • cardiac arrhythmias
  • genetics
  • cardiac pacing
  • implantable cardioverter-defibrillators
  • cardiac resynchronization therapy
  • magnetic resonance imaging
  • catheter ablation
  • arrhythmogenic disorders
  • channelopathy
  • cardiomyopathy

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 1514 KiB  
Article
The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension
by Michał Piłka, Szymon Darocha, Michał Florczyk, Rafał Mańczak, Marta Banaszkiewicz, Piotr Kędzierski, Dariusz Zieliński, Krzysztof Wróbel, Adam Torbicki and Marcin Kurzyna
J. Clin. Med. 2023, 12(24), 7621; https://doi.org/10.3390/jcm12247621 - 11 Dec 2023
Viewed by 959
Abstract
Background: The ECG-PH index (PH-ECG score) has been proposed as a valuable ECG-derived method of evaluating the effectiveness of balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary endarterectomy (PEA) is the main form of therapy for CTEPH with a proximal [...] Read more.
Background: The ECG-PH index (PH-ECG score) has been proposed as a valuable ECG-derived method of evaluating the effectiveness of balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary endarterectomy (PEA) is the main form of therapy for CTEPH with a proximal clot location. The objective of this study was to assess the clinical utility of a resting electrocardiogram (ECG-PH index) in assessing the effectiveness of PEA in CTEPH patients. Methods: The retrospective analysis included 73 patients who underwent PEA. Their ECG-PH index values were calculated using four ECG parameters: R-wave amplitude V1 + S-wave amplitude V5/V6 > 10.5 mm, QRS-wave axis > 110 degrees, R-wave amplitude V1 > S-wave amplitude V1, and SIQIII pattern. PH-ECG scores were assessed after a median time of 13 months (IQR: 8–31 months) had passed since the PEA procedures. Results: The current analysis documented that ECG-PH index = 0 is a good reflection of mPAP < 25mmHg (sensitivity 76.1%; specificity 66.7%; positive predictive value 79.5%; negative predictive value 62.1%) or mPAP ≤ 20 mmHg (sensitivity 69.6%; specificity 70.6%; positive predictive value 88.6%; negative predictive value 41.4%) after PEA. The values of the area under the ROC curve for ECG-PH index were 0.772 (95% CI: 0.676–0.867) and 0.743 (95% CI: 0.637–0.849) for the mPAP < 25 mmHg and mPAP ≤ 20 mmHg patient groups, respectively. Conclusion: The ECG-PH index may be useful for monitoring the haemodynamic effect of PEA in CTEPH patients. Full article
Show Figures

Figure 1

Back to TopTop